Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review.
Cerulli C, Busetto GM, Antonini G, Giovannone R, Di Placido M, Soda G, De Berardinis E, Gentile V.
Urol Int. 2012;88(3):365-9. Epub 2012 Jan 10.
Related citations
Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D, Liu H, Yan L, Tang Y, Ren J, Xu Z.
Urol Int. 2012;88(1):88-94. Epub 2011 Dec 9.
Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study.
Brausi MA, Gontero P, Altieri V, Colombo R, Conti I, Bono AV.
Urol Int. 2011;87(4):470-4. Epub 2011 Nov 11.
Predicting the risk of high-grade bladder cancer using noninvasive data.
Shapur N, Pode D, Katz R, Shapiro A, Yutkin V, Pizov G, Appelbaum L, Zorn KC, Duvdevani M, Landau EH, Gofrit ON.
Urol Int. 2011;87(3):319-24. Epub 2011 Aug 18.
Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells.
Wu D, Tao J, Xu B, Qing W, Li P, Lu Q, Zhang W.
Urol Int. 2011;87(1):105-13. Epub 2011 May 18.
Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer.
Kontos S, Papatsoris A, Kominea A, Melachrinou M, Tanoglidi A, Kachrilas S, Karavitakis M, Balampani E, Sotiropoulou-Bonikou G.
Urol Int. 2011;87(2):151-8. Epub 2011 Apr 22.
p53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a Taiwanese population: an implication of structural equation modeling to manage the risks of bladder cancer.
Lin HY, Huang CH, Yu TJ, Wu WJ, Yang MC, Lung FW.
Urol Int. 2011;86(3):355-60. Epub 2011 Feb 23.
Clusterin immunoreactivity as a predictive factor for progression of non-muscle-invasive bladder carcinoma.
Ekici S, Eroğlu A, Doğan Ekici AI, Türkeri L.
Urol Int. 2011 Feb;86(1):31-5. Epub 2010 Nov 19.
Unusual bladder mass in a 14-year-old boy: bladder paraganglioma.
De Pasquale V, Magistrelli A, Diomedi Camassei F, Caione P.
Urol Int. 2011 Feb;86(1):117-20. Epub 2010 Oct 22.
Urol Int. 2011;86(3):346-54. Epub 2011 Jan 27.
Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines.
Videira PA, Piteira AR, Cabral MG, Martins C, Correia M, Severino P, Gouveia H, Carrascal M, Almeida JF, Trindade H, Santos LL.
Urol Int. 2011 Feb;86(1):95-101. Epub 2011 Jan 8.
Pathological features and adverse prognosis of a contemporary series of neuroendocrine bladder tumours.
Oderda M, Ruoppolo M, Marson F, Pisano F, Fragapane G, Molinaro L, Pacchioni D, Tizzani A, Gontero P.
Urol Int. 2011;86(2):185-90. Epub 2010 Dec 21.
Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
Philippou P, Kariotis I, Volanis D, Ploumides A, Delakas D.
Urol Int. 2011;86(3):370-2. Epub 2011 Feb 16.
Evoluting the invaginated--one step closer to the perfect valve? Modified serosal lined tapered ileum (Kälble's procedure) as a continence mechanism for catheterizable pouches.
Fechner G, Rogenhofer S, Hauser S, Müller SC.
Urol Int. 2011;86(3):269-72. Epub 2011 Jan 25.
Is radical oncosurgery justified for the treatment of primary malignant fibrous histiocytoma of the urinary bladder? Report of two cases and analyses of disease-specific survival rates based on a review of the literature.
Gunia S, May M, Koch S, Erbersdobler A.
Urol Int. 2011;86(3):261-8. Epub 2011 Jan 25. Review.
Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma.
Lin Y, Sun G, Liu X, Chen Y, Zhang C.
Urol Int. 2011;86(3):340-5. Epub 2011 Jan 21.
Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
Wang J, Wang FW.
Urol Int. 2011;86(4):453-60. Epub 2011 Apr 28.
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF.
Urol Int. 2011;87(1):42-8. Epub 2011 Jun 9.
Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.
Jovanovic M, Soldatovic I, Janjic A, Vuksanovic A, Dzamic Z, Acimovic M, Hadzi-Djokic J.
Urol Int. 2011;87(2):134-7. Epub 2011 Aug 24.
Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics.
Kruck S, Bedke J, Hennenlotter J, Amend B, Merseburger A, Stenzl A, Sievert KD.
Urol Int. 2011;87(2):138-42. Epub 2011 Aug 23.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on